<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84909592215</prism:url><dc:identifier>SCOPUS_ID:84909592215</dc:identifier><eid>2-s2.0-84909592215</eid><pubmed-id>25253691</pubmed-id><prism:doi>10.1074/jbc.M114.576819</prism:doi><dc:title>A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporter</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>0</citedby-count><prism:publicationName>Journal of Biological Chemistry</prism:publicationName><dc:publisher>American Society for Biochemistry and Molecular Biology Inc.9650 Rockville PikeBethesdaMD 20814</dc:publisher><source-id>17592</source-id><prism:issn>1083351X</prism:issn><prism:volume>289</prism:volume><prism:issueIdentifier>45</prism:issueIdentifier><prism:startingPage>31397</prism:startingPage><prism:endingPage>31410</prism:endingPage><prism:pageRange>31397-31410</prism:pageRange><prism:coverDate>2014-11-07</prism:coverDate><dc:creator><author auid="56209961000" seq="1"><ce:initials>D.K.</ce:initials><ce:indexed-name>Rao D.K.</ce:indexed-name><ce:surname>Rao</ce:surname><ce:given-name>Divya K.</ce:given-name><preferred-name><ce:initials>D.K.</ce:initials><ce:indexed-name>Rao D.</ce:indexed-name><ce:surname>Rao</ce:surname><ce:given-name>Divya K.</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56209961000</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"><publishercopyright>Â© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</publishercopyright><ce:para>This paper introduces a strategy to kill selectively multidrug-resistant cells that express the ABCG2 transporter (also called breast cancer resistance protein, or BCRP). The approach is based on specific stimulation of ATP hydrolysis by ABCG2 transporters with subtoxic doses of curcumin combined with stimulation of ATP hydrolysis by Na<sup>+</sup>,K<sup>+</sup>-ATPase with subtoxic doses of gramicidin A or ouabain. After 72 h of incubation with the drug combinations, the resulting overconsumption of ATP by both pathways inhibits the efflux activity of ABCG2 transporters, leads to depletion of intracellular ATP levels below the viability threshold, and kills resistant cells selectively over cells that lack ABCG2 transporters. This strategy, which was also tested on a clinically relevant human breast adenocarcinoma cell line (MCF-7/FLV1), exploits the overexpression of ABCG2 transporters and induces caspase-dependent apoptotic cell death selectively in resistant cells. This work thus introduces a novel strategy to exploit collateral sensitivity (CS) with a combination of two clinically used compounds that individually do not exert CS. Collectively, this work expands the current knowledge on ABCG2-mediated CS and provides a potential strategy for discovery of CS drugs against drug-resistant cancer cells.</ce:para></abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84909592215" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84909592215&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84909592215%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"><affilname>University Michigan Ann Arbor</affilname></affiliation><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60006577" id="60006577"><affilname>National Institutes of Health, Bethesda</affilname></affiliation><authors><author auid="56209961000" seq="1"><ce:initials>D.K.</ce:initials><ce:indexed-name>Rao D.K.</ce:indexed-name><ce:surname>Rao</ce:surname><ce:given-name>Divya K.</ce:given-name><preferred-name><ce:initials>D.K.</ce:initials><ce:indexed-name>Rao D.</ce:indexed-name><ce:surname>Rao</ce:surname><ce:given-name>Divya K.</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56209961000</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"/></author><author auid="55387724500" seq="2"><ce:initials>H.</ce:initials><ce:indexed-name>Liu H.</ce:indexed-name><ce:surname>Liu</ce:surname><ce:given-name>Haiyan</ce:given-name><preferred-name><ce:initials>H.</ce:initials><ce:indexed-name>Liu H.</ce:indexed-name><ce:surname>Liu</ce:surname><ce:given-name>Haiyan</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/55387724500</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"/></author><author auid="7006013691" seq="3"><ce:initials>S.V.</ce:initials><ce:indexed-name>Ambudkar S.V.</ce:indexed-name><ce:surname>Ambudkar</ce:surname><ce:given-name>Suresh V.</ce:given-name><preferred-name><ce:initials>S.V.</ce:initials><ce:indexed-name>Ambudkar S.</ce:indexed-name><ce:surname>Ambudkar</ce:surname><ce:given-name>Suresh V.</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7006013691</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60006577" id="60006577"/></author><author auid="35494134200" seq="4"><ce:initials>M.</ce:initials><ce:indexed-name>Mayer M.</ce:indexed-name><ce:surname>Mayer</ce:surname><ce:given-name>Michael</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Mayer M.</ce:indexed-name><ce:surname>Mayer</ce:surname><ce:given-name>Michael</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/35494134200</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60025778" id="60025778"/></author></authors></abstracts-retrieval-response>
